Anika Therapeutics (ANIK) – Press Releases
-
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
-
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
-
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
-
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
-
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
-
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
-
Anika to Participate in Upcoming Investor Conferences
-
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
-
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
-
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
-
Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600
-
Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs
-
Anika Reports Second Quarter 2023 Financial Results
-
Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
-
Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting
-
Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone
-
Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone
-
Anika Reports First Quarter 2023 Financial Results
-
Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023
-
Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023
-
Anika Enters Into Cooperation Agreement with Caligan Partners
-
Anika Enters Into Cooperation Agreement with Caligan Partners
-
Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference
-
Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference
-
Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA
-
Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA
-
Anika Files Preliminary Proxy Statement
-
Anika Files Preliminary Proxy Statement
-
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
-
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
-
Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting
-
Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting
-
Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results
-
Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
-
Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
-
Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023
-
Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023
-
Anika Issues Statement
-
Anika Issues Statement
-
Caligan Partners Issues Open Letter to Anika Board
-
Anika Announces First Surgeries Performed Using the New RevoMotion™ Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States
-
Anika Announces First Surgeries Performed Using the New RevoMotion™ Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States
-
Anika Reports Third Quarter Fiscal 2022 Financial Results
-
Anika’s Cingal® Successfully Achieves Primary Endpoint in Third Phase III Study
-
Anika’s Cingal® Successfully Achieves Primary Endpoint in Third Phase III Study
-
Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
-
Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
-
Anika Announces First Surgeries Performed Using the X-Twist™ Fixation System and Commences Limited Market Release
Back to ANIK Stock Lookup
